Suzuka SM - Search Results

1

Corrected cerebral blood flow and reduced cerebral inflammation in berk sickle mice with higher fetal hemoglobin.

Cui MH, Billett HH, Suzuka SM, Ambadipudi K, Archarya S, Mowrey WB, Branch CA. Cui MH, et al. Among authors: suzuka sm. Transl Res. 2022 Jun;244:75-87. doi: 10.1016/j.trsl.2022.01.003. Epub 2022 Jan 25. Transl Res. 2022. PMID: 35091127

2

Brain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.

Cui MH, Suzuka SM, Branch NA, Ambadipudi K, Thangaswamy S, Acharya SA, Billett HH, Branch CA. Cui MH, et al. Among authors: suzuka sm. NMR Biomed. 2017 May;30(5). doi: 10.1002/nbm.3692. Epub 2017 Feb 10. NMR Biomed. 2017. PMID: 28186661

3

Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications.

Kaul DK, Fabry ME, Suzuka SM, Zhang X. Kaul DK, et al. Among authors: suzuka sm. Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H42-50. doi: 10.1152/ajpheart.00296.2012. Epub 2012 Nov 2. Am J Physiol Heart Circ Physiol. 2013. PMID: 23125209 Free PMC article.

4

Decreased cerebral perfusion correlates with increased BOLD hyperoxia response in transgenic mouse models of sickle cell disease.

Kennan RP, Suzuka SM, Nagel RL, Fabry ME. Kennan RP, et al. Among authors: suzuka sm. Magn Reson Med. 2004 Mar;51(3):525-32. doi: 10.1002/mrm.20014. Magn Reson Med. 2004. PMID: 15004794 Free article.

5

Second generation knockout sickle mice: the effect of HbF.

Fabry ME, Suzuka SM, Weinberg RS, Lawrence C, Factor SM, Gilman JG, Costantini F, Nagel RL. Fabry ME, et al. Among authors: suzuka sm. Blood. 2001 Jan 15;97(2):410-8. doi: 10.1182/blood.v97.2.410. Blood. 2001. PMID: 11154217 Free article.

6

Solubility measurement of the sickle polymer.

Fabry ME, Acharya SA, Suzuka SM, Nagel RL. Fabry ME, et al. Among authors: suzuka sm. Methods Mol Med. 2003;82:271-87. doi: 10.1385/1-59259-373-9:271. Methods Mol Med. 2003. PMID: 12669649 No abstract available.

7

Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.

Alami R, Gilman JG, Feng YQ, Marmorato A, Rochlin I, Suzuka SM, Fabry ME, Nagel RL, Bouhassira EE. Alami R, et al. Among authors: suzuka sm. Blood Cells Mol Dis. 1999 Apr;25(2):110-9. doi: 10.1006/bcmd.1999.0235. Blood Cells Mol Dis. 1999. PMID: 10389593

8

Transgenic mice and hemoglobinopathies.

Fabry ME, Bouhassira EE, Suzuka SM, Nagel RL. Fabry ME, et al. Among authors: suzuka sm. Methods Mol Med. 2003;82:213-41. doi: 10.1385/1-59259-373-9:213. Methods Mol Med. 2003. PMID: 12669646 No abstract available.

9

Rapid increase in red blood cell density driven by K:Cl cotransport in a subset of sickle cell anemia reticulocytes and discocytes.

Fabry ME, Romero JR, Buchanan ID, Suzuka SM, Stamatoyannopoulos G, Nagel RL, Canessa M. Fabry ME, et al. Among authors: suzuka sm. Blood. 1991 Jul 1;78(1):217-25. Blood. 1991. PMID: 1712642 Free article.

10

A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.

Fabry ME, Sengupta A, Suzuka SM, Costantini F, Rubin EM, Hofrichter J, Christoph G, Manci E, Culberson D, Factor SM, Nagel RL. Fabry ME, et al. Among authors: suzuka sm. Blood. 1995 Sep 15;86(6):2419-28. Blood. 1995. PMID: 7662990 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page